SETH WATSON: Open Payments
NPI 1659017374 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 35 payments from 11 companies in 2025. Trend: 2023 $293 · 2024 $833 · 2025 $933
Food & beverage: $818Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $234 |
| Otsuka America Pharmaceutical, Inc. | 6 | $198 |
| ABBVIE INC. | 12 | $157 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Axsome Therapeutics, Inc. | 1 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: FANAPT, VRAYLAR, ABILIFY MAINTENA, SPRAVATO, Auvelity, REXULTI, COBENFY, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
